Report cover image

ResApp Health Ltd - Strategic SWOT Analysis Review

Publisher GlobalData
Published Dec 23, 2022
Length 30 Pages
SKU # GBDT17616528

Description

ResApp Health Ltd - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

ResApp Health Ltd (ResApp), a subsidiary of Pfizer Australia Holdings Pty Ltd, is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseases. The company’s products include SleepCheck, an at-home sleep apnoea screening app for customers to self-assess their risk of sleep apnoea; and ResAppDx-EU, a smartphone based acute respiratory disease diagnostic test for respiratory disease in adults and children. ResApp has license from The University of Queensland for technology that uses sound to diagnose respiratory diseases including upper respiratory tract infections, bronchitis, pneumonia, asthma and chronic obstructive pulmonary disease (COPD). Markets for ResApp’s technology include emergency department and regular clinic use by healthcare providers, at-home use by consumers and telehealth use through partnerships with telehealth service providers. ResApp is headquartered in Brisbane, Queensland, Australia.

ResApp Health Ltd Key Recent Developments

Dec 20,2021: ResApp receives $818,826 in R&D tax incentive refund
Dec 08,2021: ResApp establishes COVID-19 Scientific Advisory Board
Sep 14,2021: ResApp receives advanced and overseas R&D finding
May 18,2021: Brian Leedman reappointed as Executive Director

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

30 Pages
Section 1 - About the Company
ResApp Health Ltd - Key Facts
ResApp Health Ltd - Key Employees
ResApp Health Ltd - Key Employee Biographies
ResApp Health Ltd - Major Products and Services
ResApp Health Ltd - History
ResApp Health Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
ResApp Health Ltd - Business Description
ResApp Health Ltd - SWOT Analysis
SWOT Analysis - Overview
ResApp Health Ltd - Strengths
ResApp Health Ltd - Weaknesses
ResApp Health Ltd - Opportunities
ResApp Health Ltd - Threats
ResApp Health Ltd - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
ResApp Health Ltd, Recent Deals Summary
Section 4 – Company’s Recent Developments
Dec 20, 2021: ResApp receives $818,826 in R&D tax incentive refund
Dec 08, 2021: ResApp establishes COVID-19 Scientific Advisory Board
Sep 14, 2021: ResApp receives advanced and overseas R&D finding
May 18, 2021: Brian Leedman reappointed as Executive Director
Mar 11, 2021: ResApp to progress clinical study to develop COVID-19 smartphone-based screening test
Feb 04, 2021: ResApp receives $801,738 in R&D tax incentive refund and grant
Jan 11, 2021: ResApp appoints VP, Commercial to progress growth strategy
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
ResApp Health Ltd, Key Facts
ResApp Health Ltd, Key Employees
ResApp Health Ltd, Key Employee Biographies
ResApp Health Ltd, Major Products and Services
ResApp Health Ltd, History
ResApp Health Ltd, Subsidiaries
ResApp Health Ltd, Key Competitors
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
ResApp Health Ltd, Recent Deals Summary
List of Figures
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us